Interleukin 1 production by human polymorphonuclear neutrophils.
The purpose of this study was to determine whether human polymorphonuclear neutrophils (PMN), which share a common cell lineage with macrophages, could produce factors such as IL 1. Other properties which these two cell types share are their phagocytic nature and the common receptor and antigens on their cell surfaces. IL 1, in many of its physical, biochemical, and functional characteristics, is found to resemble endogenous pyrogen (EP). PMN have been cited as a possible cell source of EP, but there have also been reports in which the capacity of PMN to produce EP has been questioned. This study shows that normal human PMN can be stimulated by particulate agents such as zymosan and soluble agents such as phorbol myristic acetate to produce a factor(s) which induces proliferation of mouse thymocytes, i.e., PMN IL 1. This PMN IL 1 was released from PMN in a dose- and time-dependent fashion. PMN IL 1 was nondialyzable, was heat-labile, and was inactivated at pH below 5 and above 8. PMN IL 1 stimulated the proliferation of normal human synovial fibroblasts and caused release of a neutral protease (plasminogen activator) from synovial cells. The synovial and thymocyte-proliferating capacity of PMN IL 1 was not affected by the protease inhibitor aprotinin or by soybean trypsin inhibitor. Gel filtration studies estimate the m.w. of PMN IL 1 to be approximately 13,000 to 17,000.
D000001:Calcimycin / Q000494:pharmacology; D002453:Cell Cycle; D002469:Cell Separation; D002478:Cells, Cultured; D003571:Cytochalasin B / Q000494:pharmacology; D003956:Dialysis; D010450:Endopeptidases / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology; D006358:Hot Temperature; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007375:Interleukin-1 / Q000096:biosynthesis*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation; D008970:Molecular Weight; D009000:Monocytes / Q000276:immunology; D015260:Neprilysin; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D013582:Synovial Fluid / Q000166:cytology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D015054:Zymosan / Q000494:pharmacology
D007375:Interleukin-1; D008070:Lipopolysaccharides; D011480:Protease Inhibitors; D000001:Calcimycin; D003571:Cytochalasin B; D015054:Zymosan; D010450:Endopeptidases; D015260:Neprilysin; D013755:Tetradecanoylphorbol Acetate